Jack Siemiatycki, a professor at the Université de Montréal and an epidemiologist at the University of Montreal Hospital Research Center, says restricted access to participants compromised the validity of results of the study to be published in the May 18 International Journal of Epidemiology. “The findings of the Interphone Study are ambiguous, surprising and puzzling,” he says.
The Interphone International Study Group, which examined whether cellular radio frequencies could be correlated to brain tumours, was coordinated by the International Agency for Research on Cancer. The investigation was led by 21 epidemiologists from Australia, Canada, Denmark, Finland, France, Germany, Israel, Italy, Japan, New Zealand, Norway, Sweden and the United Kingdom. Over 10,000 people took part in the study: cell phone users; non cell phone users; cell phone users who survived brain cancer as well as brain cancer survivors who had never used cell phones.
“If we combine all users and compare them with non-users, the Interphone Study found no increase in brain cancer among users. In fact, surprisingly, we found that when we combine users independently of the amount of use, they had lower brain cancer risks than non-users,” says Dr. Siemiatycki, who teaches in the Université de Montréal Faculty of Medicine. “However, the study also found heavy users of cell phones appeared to be at a higher risk of brain tumours than non-users.”
Why the discrepancy? Simply put, scientists are unsure. Attention has focused on the methodology of the study and, in particular, on the representativeness of the study subjects who participated. With participation rates in the range of 50 percent to 60 percent of eligible subjects, it is possible that the participants did not provide an accurate portrait of cell phone usage among cancer cases and among healthy control subjects. Dr. Siemiatycki argues this problem arose because of constraints imposed on researchers by ethics committees intended to protect potential research subjects.
“Ethics reviews are now so rigid that scientists from Canada, the United States and Europe are losing the kind of access to medical databases and to study subjects that is needed to conduct studies such as this one. Ethics committees increasingly require that researchers work through treating physicians, professionals who are already overworked, to recruit their patients. This may work for clinical research exploring treatment of cancer, in which physicians often have a professional or personal interest, but it does not work for investigations into the causes of cancer. This flawed system can produce biased study results.”
Despite the inconclusive results of the Interphone Study, consumers should not panic about possible risks related to cell phones, stresses Dr. Siemiatycki. “The reassuring part of our results is that 90 percent of cell phone users had absolutely no evidence of excess risk, and the controversy concerns the 10 percent of heaviest users. If there are risks, they are probably pretty small. Should anyone be concerned about potential dangers of cell phones, they can remedy the issue by using hands-free devices and avoid exposure to radio frequencies around their head.”
Partners in research:
The Quebec portion of this study was supported by the government-funded Canadian Institutes of Health Research. Overall, the Interphone International Study Group received 19.2 million Euros (€) in funding of which 5.5 million € was contributed by industry sources.
About the study:
The Quebec portion of the investigation entitled, “Case-control study of cellular phone use and risk of tumors of the brain, parotid gland and acoustic nerve,” was led by Jack Siemiatycki of the Université de Montréal and Marie-Élise Parent of the INRS—Institut Armand-Frappier.
On the Web:
- International Journal of Epidemiology
- International Agency for Research on Cancer
- Université de Montréal
- University of Montreal Hospital Research Center
- INRS—Institut Armand-Frappier
To interview Jack Siemiatycki, please contact:
International press attaché
Université de Montréal
Email: [email protected]
To obtain the Interphone Study, please contact:
Dr Nicolas Gaudin
Head, Communications Group
International Agency for Research on Cancer
Email: [email protected]